Revelation Biosciences, Inc. (NASDAQ:REVBW) Shares Shorted: Short Interest Down 63.0% in October

Revelation Biosciences, Inc. (NASDAQ:REVBW) was the recipient of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totaling 2,237 shares, a decrease of 63.0% from the September 30th total of 6,042 shares. Based on an average daily trading volume, of 30,036 shares, the days-to-cover ratio is currently 0.1 days.

Revelation Biosciences Stock Performance

REVBW stock remained flat at $0.01 during midday trading on Thursday. The company’s stock had a trading volume of 473 shares, compared to its average volume of 53,353. Revelation Biosciences has a 52-week low of $0.00 and a 52-week high of $0.04. The stock’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01.

About Revelation Biosciences

Revelation Biosciences, Inc is a clinical-stage biotechnology company focused on developing therapies that harness the body’s innate immune system to prevent and treat disease. The company’s programs are based primarily on Gemini, its proprietary formulation of an innate immune modulator designed for administration through the nose.

Revelation’s product candidates are being investigated for potential use in respiratory and other infectious diseases, with research aimed at stimulating an early immune response in the nasal passages and airways.